EP2083825A4 - Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c - Google Patents

Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c

Info

Publication number
EP2083825A4
EP2083825A4 EP06815317A EP06815317A EP2083825A4 EP 2083825 A4 EP2083825 A4 EP 2083825A4 EP 06815317 A EP06815317 A EP 06815317A EP 06815317 A EP06815317 A EP 06815317A EP 2083825 A4 EP2083825 A4 EP 2083825A4
Authority
EP
European Patent Office
Prior art keywords
hepatitis
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06815317A
Other languages
German (de)
French (fr)
Other versions
EP2083825A1 (en
Inventor
Howard L Lotsof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Addiction Research Institute Inc
Original Assignee
Addiction Research Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Addiction Research Institute Inc filed Critical Addiction Research Institute Inc
Publication of EP2083825A1 publication Critical patent/EP2083825A1/en
Publication of EP2083825A4 publication Critical patent/EP2083825A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
EP06815317A 2006-09-26 2006-09-26 Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c Withdrawn EP2083825A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/037231 WO2008039179A1 (en) 2006-09-26 2006-09-26 Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c

Publications (2)

Publication Number Publication Date
EP2083825A1 EP2083825A1 (en) 2009-08-05
EP2083825A4 true EP2083825A4 (en) 2009-11-04

Family

ID=39230475

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06815317A Withdrawn EP2083825A4 (en) 2006-09-26 2006-09-26 Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c

Country Status (4)

Country Link
EP (1) EP2083825A4 (en)
CA (1) CA2664935A1 (en)
IL (1) IL197804A0 (en)
WO (1) WO2008039179A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201107537A2 (en) 2011-08-01 2012-01-23 Tataroğlu Vedat A herbal composition for the treatment of hepatitis c disease and a method of using the herbal composition.
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
DE112012003510T5 (en) 2011-10-21 2015-03-19 Abbvie Inc. Method for the treatment of HCV comprising at least two direct-acting antiviral agents, ribavirin but not interferon
DE202012013117U1 (en) 2011-10-21 2015-01-16 Abbvie Inc. Combination treatment (e.g., with ABT-072 or ABT-333 from DAAs for use in the treatment of HCV)
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
CN104521140B (en) * 2012-07-11 2018-10-16 天工滤波方案日本有限公司 Electronic component
WO2015134405A1 (en) * 2014-03-03 2015-09-11 Demerx, Inc. Therapeutic uses of ibogaine and related compounds
US20150246055A1 (en) * 2014-03-03 2015-09-03 Demerx, Inc. Methods for acute and long-term treatment of opioid and opioid-like drug addiction
US9561233B2 (en) 2014-03-13 2017-02-07 Demerx, Inc. Use of ibogaine for the treatment of pain
US9592239B2 (en) 2014-09-12 2017-03-14 Demerx, Inc. Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake
CN109689063A (en) 2016-04-28 2019-04-26 埃默里大学 Nucleotide containing alkynes and nucleosides therapeutic combination and its associated uses
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
CA3138094A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001070203A2 (en) * 2000-03-22 2001-09-27 Nowicky Wassili Agent for treating hepatitis c containing ukrain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5152994A (en) * 1990-05-31 1992-10-06 Lotsof Howard S Rapid method for interrupting or attenuating poly-drug dependency syndromes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001070203A2 (en) * 2000-03-22 2001-09-27 Nowicky Wassili Agent for treating hepatitis c containing ukrain

Also Published As

Publication number Publication date
EP2083825A1 (en) 2009-08-05
WO2008039179A1 (en) 2008-04-03
IL197804A0 (en) 2009-12-24
CA2664935A1 (en) 2008-04-03

Similar Documents

Publication Publication Date Title
IL197804A0 (en) Compositions for the trearment of hepatitis c and methods for using compositions for the treatment of hepatitis c
EP2331123A4 (en) Compositions and methods for the treatment of hepatitis c
HK1134679A1 (en) Compositions and methods for the treatment of infections
EP2361089A4 (en) Compositions and methods for the treatment of altered -synuclein function
IL181896A0 (en) Methods and compositions for the treatment of hyperlipidemia
IL197148A0 (en) Methods and compositions for the treatment of antibody mediated neuropathies
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
ZA200900388B (en) Compositions and methods for the treatment of mucositis
ZA200808431B (en) Fungicidal compositions and methods of using the same
AP2009004840A0 (en) Compounds and methods for treatment of HCV
IL195272A0 (en) Methods and compositions for the treatment of viral infections
EP2049151A4 (en) Methods and compositions for the treatment of cancer
GB0718446D0 (en) Compositions and methods for the treatment of infection
IL198723A0 (en) Methods and compositions for therapeutic treatment
ZA200703087B (en) Methods and compositions for the treatment of hyperlipidemia
AU2007243282A8 (en) Compositions and methods for the treatment of cardiovascular disease
IL186325A0 (en) Tizanidine compositions and methods of treatment using the compositions
EP2124968A4 (en) Compositions and methods for the treatment of muscle wasting
IL187405A0 (en) Methods and compositions for the treatment of pain
EP2007381A4 (en) Compositions and methods of use of ritonavir for treating hcv
EP2150270A4 (en) Methods and compositions for the treatment of cancer
EP2096927A4 (en) Therapeutic compositions and methods of treatment with capsianoside-type compounds
EP1996211A4 (en) Gallium compositions for the treatment of liver cancer and methods of use
EP1904088A4 (en) Compositions and methods for the treatment of cancer
EP2142566A4 (en) Methods and compositions for the treatment of proliferative diseases

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090427

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20091005

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/55 20060101AFI20080421BHEP

Ipc: A61P 31/14 20060101ALI20090929BHEP

Ipc: A61K 31/22 20060101ALI20090929BHEP

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20100409

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100820